Painchek Ltd has released a press release.
nViso agrees perpetual global license, takes strategic stake
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from PainChek
- ePAT Pain Assessment App Secures Regulatory Clearance
- New Study Validates Face Recognition App in Pain Detection
- Launch of IBM Case Study
- Second Quarter Report FY 2016/17
- Market Update
Later from PainChek
- ePAT Clinical Study Published in Alzheimers Disease Journal
- Core strategic agreement with Dementia Support Australia
- Placement to raise $3.75 million
- ePAT and PainChek continue to achieve commercial milestones
- 2nd peer-review confirms excellent performance of PainChek
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek